Evidence map›Paper›PMID 34275903›Full record

ArticleJournal of Alzheimer's disease : JAD2021

Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.

Peter L Nara, Daniel Sindelar, Marc S Penn, Jan Potempa, W Sue T Griffin

Open access · hybridAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Deciphering macrophage molecular responses toFrontiers in microbiology · 2026
    Article
  5. Review
  6. Article
  7. Oral microbiota and central nervous system diseases: A review.Neuroprotection (Chichester, England) · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Alzheimer's Disease andLife (Basel, Switzerland) · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Peter L NaraKeystone Bio Inc., St. Louis, MO, USA.
Daniel SindelarKeystone Bio Inc., St. Louis, MO, USA.
Marc S PennSumma Heart Health and Vascular Institute, Akron, OH, USA.
Jan PotempaDepartment of Oral Immunology and Infectious Diseases in the School of Dentistry, University of Louisville, Louisville, KY, USA.
W Sue T GriffinDepartment of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Summa Health System · USUniversity of Arkansas for Medical Sciences · USUniversity of Louisville · US

Funding

THE APOE-APP AXIS IN ALZHEIMER PATHOGENESISP01AG012411 · NIA · UNIV OF ARKANSAS FOR MED SCIS · PI SHMOOKLER REIS, ROBERT JOSEPH · 1995 to 2020
$25.0M
NIA NIH HHS P01 AG012411
6 · The paper itself

Abstract

Porphyromonas gingivalis (Pg) is a primary oral pathogen in the widespread biofilm-induced "chronic" multi-systems inflammatory disease(s) including Alzheimer's disease (AD). It is possibly the only second identified unique example of a biological extremophile in the human body. Having a better understanding of the key microbiological and genetic mechanisms of its pathogenesis and disease induction are central to its future diagnosis, treatment, and possible prevention. The published literature around the role of Pg in AD highlights the bacteria's direct role within the brain to cause disease. The available evidence, although somewhat adopted, does not fully support this as the major process. There are alternative pathogenic/virulence features associated with Pg that have been overlooked and may better explain the pathogenic processes found in the "infection hypothesis" of AD. A better explanation is offered here for the discrepancy in the relatively low amounts of "Pg bacteria" residing in the brain compared to the rather florid amounts and broad distribution of one or more of its major bacterial protein toxins. Related to this, the "Gingipains Hypothesis", AD-related iron dyshomeostasis, and the early reduced salivary lactoferrin, along with the resurrection of the Cholinergic Hypothesis may now be integrated into one working model. The current paper suggests the highly evolved and developed Type IX secretory cargo system of Pg producing outer membrane vesicles may better explain the observed diseases. Thus it is hoped this paper can provide a unifying model for the sporadic form of AD and guide the direction of research, treatment, and possible prevention.

Indexed as

Cholinergic AgentsSalivaAlzheimer DiseaseAnti-Infective AgentsBacterial Outer Membrane ProteinsBacteroidaceae InfectionsBrainExtremophilesHumansIronLactoferrinPorphyromonas gingivalisAnti-Infective AgentsBacterial Outer Membrane ProteinsCholinergic AgentsIronLactoferrinAlzheimer’s diseasebiological extremophilecholinergic hypothesisdementiaouter membrane vesiclesPorphyromonas gingivalissystemic inflammation

Identifiers

PMID34275903
PMCPMC8461682
OpenAlexW3185060246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.